ASX Share rice
Thu 13 May 2021 - 01:17:pm (Sydney)

MDC Share Price

MEDLAB CLINICAL LIMITEDMDCPharmaceuticals, Biotechnology & Life Sciences

MDC Company Information

Name:

Medlab Clinical Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Biotechnology

GIC Sub Industry:

Biotechnology

Address:

66 McCauley Street Alexandria NSW Australia 2015

Phone:

61 2 8188 0311

CEO & Director:

Dr. Sean Michael Hall

Chief Information Officer:

Mr. Ian Curtinsmith

Company Sec. & Non-Exec. Director:

Mr. Drew Anthony Townsend

Director of Medical Research:

Dr. Luis Vitetta BSc(Hons), Grad Dip, Ph.D., Grad Dip Nutr

Director of Science:

Dr. David A. Rutolo

Chief Financial Officer:

Mr. Simon Allsop

Director of Pharmaceuticals Sales, Marketing & Education:

Mr. Tony Potter

Company Overview:

Medlab Clinical Limited, a medical research and development facility, engages in the nutraceutical products and pharmaceutical research businesses in Australia. The company develops bio-therapeutics for chronic kidney diseases, pre-diabetes/obesity, depression, musculoskeletal muscle loss associated with ageing, and non-opioid pain management. It also provides nutraceuticals for anti-inflammatory, cardiovascular support, endocrine support, gastrointestinal support, immunological support, infants and toddlers, metabolic support, musculoskeletal support, neurological support, sports performance, urogenital support, and weight management, as well as for men, pregnancy, seniors, teenagers, and women support. Medlab Clinical Limited was founded in 2012 and is headquartered in Botany, Australia.

MDC Share Price Information

Shares Issued:

342.18M

Market Capitalisation:

$59.88M

Revenue (TTM):

$2.95M

Revenue Per Share (TTM):

$0.01

Earnings per Share:

$-0.039

Operating Margin (TTM):

$-3.92

Return On Assets (TTM):

$-0.44

Return On Equity (TTM):

$-1.13

Quarterly Revenue Growth (YOY):

0.051

Gross Profit(TTM):

$-851,482

Diluted Earnings Per Share (TTM):

$-0.045

MDC CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$-243,075

Change To Liabilities:

$-781,860

Total Cashflow From Investing Activities:

$-243,075

Net Borrowings:

$-1,513,007

Net Income:

$-13,399,374

Total Cash From Operating Activities:

$-10,422,420

Depreciation:

$0.96M

Change To Inventory:

$744.82K

Change To Account Receivables:

$434.74K

Sale Purchase Of Stock:

$10.40M

Capital Expenditures:

$243.08K

MDC Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-13,488,320

Net Income:

$-13,399,370

Gross Profit:

$2.53M

Operating Income:

$-13,735,620

Other Operating Expenses:

$-264,328

Interest Expense:

$197.29K

Total Revenue:

$5.37M

Cost Of Revenue:

$2.84M

MDC Balance Sheet

Balance Sheet Date:

2020-06-30

Total Liabilities:

$6.39M

Total Stockholder Equity:

$11.40M

Other Current Liabilities:

$553.90K

Total Assets:

$17.79M

Common Stock:

$51.36M

Other Current Assets:

$146.36K

Retained Earnings:

$-40,042,955

Other Liabilities:

$477.67K

Other Assets:

$482.94K

Cash:

$9.06M

Total Current Liabilities:

$4.43M

Short-Term Debt:

$94.22K

Property - Plant & Equipment:

$2.88M

Net Tangible Assets:

$11.40M

Long-Term Investments:

$482.94K

Total Current Assets:

$14.42M

Net Receivables:

$3.38M

Short-Term Investments:

$3.36M

Inventory:

$1.47M

Accounts Payable:

$1.82M

Short-Term Investments:

$3.36

Non Current Liabilities Total:

$2.11M

MDC Share Price History

MDC News

17 Dec, 2020
We feel now is a pretty good time to analyse Medlab Clinical Limited's ( ASX:MDC ) business as it appears the company...
19 Oct, 2020
The CEO of Medlab Clinical Limited (ASX:MDC) is Sean Hall, and this article examines the executive's compensation...